Disaccharides

• 

  Subject Areas on Research

  • A comparison of the fine saccharide-binding specificity of Dioclea grandiflora lectin and concanavalin A. 
  • Another step towards xenotransplantation. 
  • Antigen expression in xenotransplantation: how low must it go? 
  • Biophysical characteristics of anti-Gal(alpha)1-3Gal IgM binding to cell surfaces: implications for xenotransplantation. 
  • Cardiac xenografts between primate species provide evidence for the importance of the alpha-galactosyl determinant in hyperacute rejection. 
  • Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose. 
  • Characterization of xenoreactive natural antibodies: interactions with carbohydrate determinants. 
  • Diagnosis of Life-Threatening Alpha-Gal Food Allergy Appears to Be Patient Driven. 
  • Differential recognition by proteins of alpha-galactosyl residues on endothelial cell surfaces. 
  • Disaccharidase activities and fat assimilation in pediatric patients after intestinal transplantation. 
  • Distribution of, and immune response to, chicken anti-alpha Gal immunoglobulin Y antibodies in wild-type and alpha Gal knockout mice. 
  • Evidence for polyreactive xenoreactive antibodies in the repertoire of human anti-swine antibodies: the 'next' humoral barrier to xenotransplantation? 
  • Exposure to topical bovine thrombin during surgery elicits a response against the xenogeneic carbohydrate galactose alpha1-3galactose. 
  • Fate of antigen in xenotransplantation: implications for acute vascular rejection and accommodation. 
  • Galactose-α-1,3-galactose and delayed anaphylaxis, angioedema, and urticaria in children. 
  • Glucose activates mitogen-activated protein kinase (extracellular signal-regulated kinase) through proline-rich tyrosine kinase-2 and the Glut1 glucose transporter. 
  • Identification and characterization of a galactosyl peptide mimetic. Implications for use in removing xenoreactive anti-A Gal antibodies. 
  • Identification and characterization of a peptide mimeotope of galactose alpha 1,3 galactose. 
  • Immunochemical properties of anti-Gal alpha 1-3Gal antibodies after sensitization with xenogeneic tissues. 
  • Interaction of the Shiga-like toxin type 1 B-subunit with its carbohydrate receptor. 
  • Intravesical rAd-IFNα/Syn3 for Patients With High-Grade, Bacillus Calmette-Guerin-Refractory or Relapsed Non-Muscle-Invasive Bladder Cancer: A Phase II Randomized Study. 
  • Isohemagglutinins and xenoreactive antibodies: members of a distinct family of natural antibodies. 
  • Modulation of natural IgM binding and complement activation by natural IgG antibodies: a role for IgG anti-Gal alpha1-3Gal antibodies. 
  • Molecular barriers to xenotransplantation. 
  • Osmoltye and tryptophan receptors controlling gastric emptying in the dog. 
  • Relative purity of thrombin-based hemostatic agents used in surgery. 
  • Role of the microvillus in the absorption of disaccharides. 
  • Sensitization with xenogeneic tissues alters the heavy chain repertoire of human anti-Galalpha1-3Gal antibodies. 
  • Specificity and function of "natural" antibodies in immunodeficient subjects: clues to B cell lineage and development. 
  • Specificity of xenoreactive anti-Gal alpha 1-3Gal IgM for alpha-galactosyl ligands. 
  • Structural adaptations that modulate monosaccharide, disaccharide, and trisaccharide specificities in periplasmic maltose-binding proteins. 
  • The crystal structure of a thermophilic glucose binding protein reveals adaptations that interconvert mono and di-saccharide binding sites. 
  • The footprint of antibody bound to pig cells: evidence of complex surface topology. 
  • The humoral immune response in humans following ex vivo perfusion of porcine livers. 
  • The potential of xenotransplants. 
  • The role of anti-Galalpha1-3Gal antibodies in acute vascular rejection and accommodation of xenografts. 
  • The role of antibodies and von Willebrand factor in discordant pulmonary xenotransplantation. 
  • The role of natural anti-Gal alpha 1-3Gal antibodies in hyperacute rejection of pig-to-baboon cardiac xenotransplants. 
  • Variation in expression of biologically reactive xenoantigen does not correlate with expression of Gal alpha (1-3)Gal.